Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262412128 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rakhi Chowdhury und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 4040 Emile Street, Omaha, NE 68198-6120, USA. Hauptthemen laut MEDLINE: tau Proteins, Amyloid beta-Peptides, Protein Aggregates, Peptide Fragments. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIH/NIGMS.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is characterized by the accumulation and aggregation of tau and amyloid-β (Aβ). The pathophysiology and progression of AD are facilitated by the neurotoxic effects of these aggregated proteins, resulting in neurodegeneration and memory loss. In this context, the interaction between tau and Aβ42 is considered, but the mechanism underlying their pathogenic interplay remains unclear. Here, we addressed this question by studying the aggregation of full-length, unmodified tau and Aβ42 at physiologically low concentrations using atomic force microscopy (AFM). AFM imaging and data analyses demonstrate an increase in tau aggregation in the presence of Aβ42, characterized by increased sizes and number of aggregates. Importantly, tau aggregation occurs without the need for phosphorylation or any other post-translational changes. The analysis of the data demonstrates that tau and Aβ42 form co-aggregates, with no visible accumulation of Aβ42 aggregates alone. Given that the catalysis of tau aggregation by Aβ42 is observed at physiological low nanomolar concentrations of Aβ42, the finding suggests that such aggregation catalysis of tau by Aβ42 can be a molecular mechanism underlying the pathological tau aggregation process associated with the onset and development of Alzheimer’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 4040 Emile Street, Omaha, NE 68198-6120, USA.
- Department of Biostatistics, University of Nebraska Medical Center, 4040 Emile Street, Omaha, NE 68198-6120, USA.
ORCID-Profile: Rakhi Chowdhury, Apu Chandra Das, Yuri L Lyubchenko
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIH/NIGMS
Zitieren
APA
Chowdhury, R., Das, A. C., van Deventer, R., Shlyakhtenko, L. S., & Lyubchenko, Y. L. (2025). Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412128
Vancouver
Chowdhury R, Das AC, van Deventer R, Shlyakhtenko LS, Lyubchenko YL. Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412128
BibTeX
@article{Chowdhury2025,
author = {Chowdhury, Rakhi and Das, Apu Chandra and van Deventer, Ruan and Shlyakhtenko, Luda S and Lyubchenko, Yuri L},
title = {Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262412128}
}
EUVIMED